Bubblr (BBLR) 10-Q 15 May 23 2023 Q1 Quarterly report Financial data

Cover

Cover - shares	3 Months Ended
	Mar. 31, 2023	May 12, 2023
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Mar. 31, 2023
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2023
Current Fiscal Year End Date	--12-31
Entity File Number	333-260902
Entity Registrant Name	Bubblr, Inc.
Entity Central Index Key	0001873722
Entity Tax Identification Number	86-2355916
Entity Incorporation, State or Country Code	WY
Entity Address, Address Line One	21 West 46th Street
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10036
City Area Code	646
Local Phone Number	814 7184
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		156,261,278

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Current Assets:
Cash	$ 35,115	$ 32,533
Other receivables	6,240	9,884
Total current assets	41,355	42,417
Non-current Assets:
Property and equipment, net	45,800	47,956
Intangible assets, net	1,306,093	1,325,995
Total non-current assets	1,351,893	1,373,951
TOTAL ASSETS	1,393,248	1,416,368
Current Liabilities:
Accounts payable	393,973	141,605
Accrued liabilities	96,331	50,094
Loan payable, current portion	12,225	11,987
Loan payable - related party	636,261	392,170
Total current liabilities	1,138,790	595,856
Non-current liabilities:
Loan payable, non-current portion	8,205	10,465
Loan payable, related party, non-current portion	535,709	525,291
Warrant derivative liability	270,998	198,479
Total non-current liabilities	814,912	734,235
Total Liabilities	1,953,702	1,330,091
Stockholders' Equity (Deficit)
Common stock, $0.01 par value, 3,000,000,000 shares authorized; 155,948,778 and 154,309,318 shares issued and outstanding at March 31, 2023 and December 31, 2022	1,559,488	1,543,093
Additional paid-in capital	10,638,631	11,006,607
Accumulated deficit	(13,151,445)	(12,875,437)
Accumulated other comprehensive income	392,871	412,013
Total Stockholders' Equity (Deficit)	(560,454)	86,277
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	1,393,248	1,416,368
Series C Preferred Stock [Member]
Stockholders' Equity (Deficit)
Preferred Stock, Value, Issued	$ 1	$ 1

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2023	Dec. 31, 2022	Mar. 04, 2022
Preferred Stock, Par or Stated Value Per Share	$ 0.001
Preferred Stock, Shares Authorized	25,000,000
Preferred Stock, Shares Issued		903
Common Stock, Par or Stated Value Per Share		$ 0.01
Common Stock, Shares Authorized		3,000,000,000
Common Stock, Shares, Outstanding	155,948,778	154,309,318
Series C Preferred Stock [Member]
Preferred Stock, Par or Stated Value Per Share		$ 0.001
Preferred Stock, Shares Authorized		2,000	2,000
Preferred Stock, Shares Issued		903

Consolidated Statements of Oper

Consolidated Statements of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Operating Expenses
General and administrative	$ 47,625	$ 11,119
Professional fees	(225,570)	192,829
Market and regulation costs	312,463	37,593
Compensation	(31,336)	140,944
Amortization and depreciation	59,627	107,595
Research and development	39,152	61,261
Total operating expense	201,961	551,341
Operating loss	(201,961)	(551,341)
Other income (expense)
Interest income	98	452
Interest expense	(1,129)	(414,844)
Loss on change in fair value of warrant derivative liability	(72,519)	(23,891)
Foreign currency transaction gain (loss)	21,175	(40,707)
Total other income (expense)	(52,375)	(478,990)
Net loss before income tax	(254,336)	(1,030,331)
Provision for income tax
Net loss after income tax	(254,336)	(1,030,331)
Other comprehensive income (loss)
Foreign currency translation gain (loss)	(19,142)	13,373
Total other comprehensive income (loss)	(19,142)	13,373
Net comprehensive loss	$ (273,478)	$ (1,016,958)
Net loss per common share, basic and diluted	$ 0	$ (0.01)
Weighted average number of common shares outstanding, basic and diluted	154,904,171	140,499,144

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders' Equity (Deficit) - USD ($)	Preferred Stock [Member] Series A Preferred Stock [Member]	Preferred Stock [Member] Series B Preferred Stock [Member]	Preferred Stock [Member] Series C Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Comprehensive Income [Member]	Total
Balance - December 31, 2022 at Dec. 31, 2021				$ 1,401,861	$ 5,478,801	$ (8,385,496)	$ 377,244	$ (1,127,590)
Shares, Issued at Dec. 31, 2021	1			140,186,096
Issuance of common shares for Services - Advisory Board				$ 1,480	73,980			75,460
Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture				147,960
Issuance of common shares for Services – Consulting				$ 193	8,787			8,980
Stock Issued During Period, Shares, Issued for Services				19,250
Issuance of common shares for Equity Finance Agreement Incentive				$ 7,930	371,884			379,814
[custom:StockIssuedDuringPeriodEquityFinanceAgreementShares]				793,039
Issuance of Series C Preferred Stock			$ 1		(1)
Stock Issued During Period, Shares, New Issues			503
Dividend Series C Preferred Stock						(3,272)		(3,272)
[custom:DividendSeriesCPreferredStockShares]
Net loss						(1,030,331)		(1,030,331)
Other comprehensive loss							13,373	13,373
[custom:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestShares]
Forfeit of restricted stock units
Balance -March 31, 2023 at Mar. 31, 2022			$ 1	$ 1,411,464	5,933,451	(9,419,099)	390,617	(1,683,566)
Shares, Issued at Mar. 31, 2022	1		503	141,146,345
Balance - December 31, 2022 at Dec. 31, 2021				$ 1,401,861	5,478,801	(8,385,496)	377,244	(1,127,590)
Shares, Issued at Dec. 31, 2021	1			140,186,096
Net loss								(254,336)
Other comprehensive loss								(19,142)
Balance -March 31, 2023 at Dec. 31, 2022			$ 1	$ 1,543,093	11,006,607	(12,875,437)	412,013	86,277
Shares, Issued at Dec. 31, 2022			903	154,309,318
Issuance of common shares for Services – Consulting				$ 14,558	270,780			285,338
Stock Issued During Period, Shares, Issued for Services				1,455,784
Dividend Series C Preferred Stock						(21,672)		(21,672)
[custom:DividendSeriesCPreferredStockShares]
Net loss						(254,336)		(254,336)
Other comprehensive loss							(19,142)	(19,142)
[custom:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestShares]
Forfeit of restricted stock units					(659,052)			(659,052)
[custom:RestrictedStockAwardForfeituresShares]
Issuance of common shares for Series C Preferred Shares Dividend				$ 1,837	20,296			22,133
Stock Dividends, Shares				183,676
Balance -March 31, 2023 at Mar. 31, 2023			$ 1	$ 1,559,488	$ 10,638,631	$ (13,151,445)	$ 392,871	$ (560,454)
Shares, Issued at Mar. 31, 2023			903	155,948,778

Consolidated Statements of Cash

Consolidated Statements of Cashflows (Unaudited) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Cash Flows from Operating Activities:
Net loss	$ (254,336)	$ (1,030,331)
Net loss to net cash used in operating activities:
Stock based compensation	285,338	84,440
Stock based finance incentive		379,814
Forfeit of restricted stock units	(659,052)
Loss on change in fair value of warrant derivative liability	72,519	23,891
Amortization of debt discount		22,429
Amortization of intangible asset	56,521	101,193
Depreciation	3,106	4,223
Changes in operating assets and liabilities:
Decrease in accounts receivable	3,778	2,581
Increase (decrease) in accrued liabilities	(3,156)	10,985
Increase (decrease) in accounts payable	336,901	(3,523)
Net cash used in operating activities	(158,381)	(404,298)
Cash flows from investing activities
Purchase of intangible assets	(11,138)	(11,684)
Net cash used in investing activities	(11,138)	(11,684)
Cash flows from financing activities
Repayment of loans payable	(2,430)	(3,322)	$ (3,322)
Repayment of loans payable - related party	(18,228)	(52,556)
Proceeds from loans payable - related party	223,777	19,709
Net proceeds from issuance of Series C Preferred stock		421,000
Proceeds from issuance of convertible notes payable		15,000
Net cash provided by financing activities	203,119	399,831
Effects of exchange rate changes on cash	(31,018)	46,676
Net Change in Cash	2,582	30,525
Cash - Beginning of Period	32,533	62,967	62,967
Cash - End of Period	35,115	93,492	$ 32,533
Supplemental information:
Cash paid for interest	4,774	5,712
Cash paid for taxes
Non-cash investing and financing activities
Warrant liability		449,043
Declared dividends	21,672	3,272
Common stock issued in satisfaction of dividend payable	$ 22,133

NOTE 1 - ORGANIZATION, BUSINESS

NOTE 1 - ORGANIZATION, BUSINESS AND LIQUIDITY	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
NOTE 1 - ORGANIZATION, BUSINESS AND LIQUIDITY	NOTE 1 - ORGANIZATION, BUSINESS AND LIQUIDITY Organization and Operations On March 26, 2020, Bubblr Holdings Ltd. (a UK company formed on February 18, 2016) merged into U.S. Wireless Online, Inc. (“UWRL”), a Wyoming corporation formed on October 22, 2019 100% Bubblr, Inc. is a Mobile Application software company that is currently developing its disruptive Internet Search Mechanism and seeking license opportunities for a next-generation solution designed to create an alternative economic model. Going Concern Matters The accompanying consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America (“GAAP”), which contemplates the Company’s continuation as a going concern. The Company incurred a net comprehensive loss of $273,478 $13,151,445 $1,097,435 Management intends to raise additional operating funds through equity and/or debt offerings. However, there can be no assurance management will be successful in its endeavors. There are no assurances that the Company will be able to either (1) achieve a level of revenues adequate to generate sufficient cash flow from operations; or (2) obtain additional financing through either private placement, public offerings, and/or bank financing necessary to support its working capital requirements. To the extent that funds generated from operations and any private placements, public offerings, and/or bank financing are insufficient, the Company will have to raise additional working capital. No assurance can be given that additional financing will be available, or if available, will be on terms acceptable to the Company. If adequate working capital is not available to the Company, it may be required to curtail or cease its operations. Due to uncertainties related to these matters, there exists substantial doubt about the ability of the Company to continue as a going concern. The accompanying consolidated financial statements do not include any adjustments related to the recoverability or classification of asset-carrying amounts or the amounts and classification of liabilities that may result should the Company be unable to continue as a going concern. COVID-19 A novel strain of coronavirus (COVID-19) was first identified in December 2019 and subsequently declared a global pandemic by the World Health Organization on March 11, 2020. As a result of the outbreak, many companies have experienced disruptions in their operations and in the markets served. The Company has instituted some and may take additional temporary precautionary measures intended to help ensure the well-being of its employees and minimize business disruption. The Company considered the impact of COVID-19 on the assumptions and estimates used and determined that there were no material adverse impacts on the Company’s results of operations and financial position as at March 31, 2023. The full extent of the future impacts of COVID-19 on the Company’s operations is uncertain. A prolonged outbreak could have a material adverse impact on the financial results and business operations of the Company, including the timing and ability of the Company to collect accounts receivable and the ability of the Company to continue to provide high-quality services to its clients. The Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities at the date of issuance of these financial statements. These estimates may change as new events occur, and additional information is obtained.

NOTE 2 - SIGNIFICANT ACCOUNTING

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying consolidated interim financial statements have been prepared in accordance with GAAP. The Company’s fiscal year-end is December 31. Principles of Consolidation The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries: Bubblr Holdings Ltd., Bubblr Ltd., and Bubblr CLN Ltd. All significant inter-company balances and transactions have been eliminated in consolidation. Use of Estimates The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Some of these judgments can be subjective and complex, and, consequently, actual results may differ from these estimates. Convertible Financial Instruments The Company bifurcates conversion options from their host instruments and accounts for them as free-standing derivative financial instruments if certain criteria are met. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not remeasured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur, and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. An exception to this rule is when the host instrument is deemed to be conventional, as that term is described under applicable GAAP. Fair Value of Financial Instruments The Company accounts for financial instruments in accordance with ASC 820, “Fair Value Measurements and Disclosures.” ASC 820 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy under ASC 820 are described below: Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. Level 2 – Quoted prices in non-active markets or in active markets for similar assets or liabilities, observable inputs other than quoted prices, and inputs that are not directly observable but are corroborated by observable market data. Level 3 – Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable. The carrying value of the Company’s current assets and liabilities are deemed to be their fair value due to the short-term maturity and realization. During the year ended December 31, 2022, the Company acquired warrant derivative liabilities, which are Level 3 financial instruments that are adjusted to fair market value on reporting dates. At March 31, 2023 and December 31, 2022 the warrant liabilities balances were $270,998 $198,479 Stock Based Compensation We follow ASC Topic 718, Compensation–Stock Compensation, Restricted stock units (“RSUs”) issued as compensation in accordance with the Company’s 2022 Equity Incentive Plan are deemed to be unissued until fully vested. RSU compensation is recognized as expense over the vesting period. Upon repurchase of the award any unrecognized compensation, net of cash payments are expensed immediately. Awards forfeited due to unfulfillment of obligations, such as termination of employment prior to the award being fully vested, for no cash or other consideration, are not recognized as an expense and any previously recognized costs are reversed in the period of forfeiture. Common Stock Purchase Warrants and Derivative Financial Instruments Common stock purchase warrants and other derivative financial instruments are classified as equity if the contracts (1) require physical settlement or net-share settlement or (2) give the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). Contracts which (1) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company), (2) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement), or (3) that contain reset provisions that do not qualify for the scope exception are classified as liabilities. The Company assesses the classification of its common stock purchase warrants and other derivatives at each reporting date to determine whether a change in classification between equity and liabilities is required. Basic and Diluted Net Loss per Common Share Pursuant to ASC 260, “Earnings Per Share,” basic net income and net loss per share are computed by dividing the net income and net loss by the weighted average number of common shares outstanding. Diluted net income and net loss per share is the same as basic net income and net loss per share when their inclusion would have an anti-dilutive effect due to our continuing net losses. For the three months ended March 31, 2023 and 2022, the following outstanding stock was excluded from the computation of diluted net loss per share as the result of the computation was anti-dilutive. March 31, 2023 2022 (Shares) (Shares) Series C Preferred Stock 3,384,135 1,885,072 Warrants 2,358,101 1,413,804 Convertible Notes — 2,007,994 Total 5,742,236 5,306,870 Foreign Currency Translations The functional currency of the Company’s international subsidiaries is generally their local currency of Great British pounds (GBP). Local currency assets and liabilities are translated at the rates of exchange on the balance sheet date, and local currency revenues and expenses are translated at weighted average rates of exchange during the period. Equity accounts are translated at historical rates. The resulting translation adjustments are recorded directly into accumulated other comprehensive income. March 31, December 31, 2023 2022 2022 Period-end GBP£:US$ exchange rate 1.2341 1.3139 1.2101 Weighted average GBP£:US$ exchange rate 1.2152 1.3412 1.2430 Aggregate transaction gains or losses, including gains or losses related to foreign-denominated cash and cash equivalents and the re-measurement of certain inter-company balances, are included in the statement of operations as other income and expense. Gains on foreign exchange transactions totaling $21,175 $40,707 Income Taxes The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, “Income Taxes”. The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized. As of March 31, 2023 and December 31, 2022, the Company did not have any amounts recorded pertaining to uncertain tax positions. UK Taxes We do not consider ourselves to be engaged in a trade or business in the UK and, as such, do not expect to be subject to UK corporate income taxation. We have subsidiaries based in the UK that are subject to the tax laws of that country. Under current law, those subsidiaries are taxed at the applicable corporate income tax rates. Should any UK subsidiaries be deemed to undertake business activities in the US, they would be subject to US corporate income tax in respect of their US activities only. Relief would then be available against the UK tax liabilities in respect of the overseas taxes arising from US activities. At present, this is not applicable as our UK subsidiaries only undertake activities in the UK. Our UK subsidiaries file separate UK income tax returns. UK Tax Risk Companies that are incorporated outside the UK may become subject to UK taxes in a number of circumstances, including circumstances in which (1) they are deemed resident in the UK for tax purposes by reason of their central management and control being exercised from the UK or (2) they are treated as carrying on a trade, investing or carrying on any other business activity in the UK, whether or not through a UK Permanent Establishment (“PE”). In addition, the Finance Act 2015 introduced a new tax known as the diverted profits tax (“DPT”), which is charged at 25% However, this result is based on certain legal and factual determinations, and since the scope and the basis upon which the DPT will be applied by HM Revenue & Customs (“HMRC”) in the UK remains uncertain and since applicable law and regulations do not conclusively define the activities that constitute conducting a trade, investment or business activity in the UK (whether or not through a UK PE), and since we cannot exclude the possibility that there will be a change in law that adversely affects the analysis, HMRC might successfully assert a contrary position. The terms of an income tax treaty between the UK and the home country of the relevant Bubblr subsidiary, if any, could contain additional protections against UK tax. Any arrangements between UK-resident entities of Bubblr and other entities of Bubblr are subject to the UK transfer pricing regime. Consequently, if any agreement between a UK resident entity of Bubblr and any other Bubblr entity (whether that entity is resident in or outside of the UK) is found not to be on arm’s length terms and, as a result, a UK tax advantage is being obtained, an adjustment will be required to compute UK taxable profits as if such an agreement were on arm’s length terms. Any transfer pricing adjustment could adversely impact the tax charge incurred by the relevant UK resident entities of Bubblr. Recent Accounting Pronouncements The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on our financial statements.

NOTE 3 _ OTHER RECEIVABLES

NOTE 3 – OTHER RECEIVABLES	3 Months Ended
	Mar. 31, 2023
Credit Loss [Abstract]
NOTE 3 – OTHER RECEIVABLES	NOTE 3 – OTHER RECEIVABLES As of March 31, 2023 and December 31, 2022, accounts receivable consisted of the following: March 31, December 31, 2023 2022 Deposit $ 200 $ 200 UK VAT Receivable 6,040 9,684 Other receivables $ 6,240 $ 9,884 Any nominal change in the deposit value is due to exchange rate fluctuation .

NOTE 4 - PROPERTY AND EQUIPMENT

NOTE 4 - PROPERTY AND EQUIPMENT	3 Months Ended
	Mar. 31, 2023
Property, Plant and Equipment [Abstract]
NOTE 4 - PROPERTY AND EQUIPMENT	NOTE 4 - PROPERTY AND EQUIPMENT As of March 31, 2023 and December 31, 2022, property and equipment consisted of the following: Motor Vehicles Computer Equipment Office Equipment Total Cost At December 31, 2022 $ 56,875 $ 28,179 $ 563 $ 85,617 Additions — — — — Effects of currency translation 1,128 558 11 1,697 At March 31, 2023 $ 58,003 $ 28,737 $ 574 $ 87,314 Less accumulated depreciation At December 31, 2022 $ 18,659 $ 18,636 $ 366 $ 37,661 Depreciation expense 1,543 1,535 28 3,106 Effects of currency translation 370 370 7 747 At March 31, 2023 $ 20,572 $ 20,541 $ 401 $ 41,514 Net book value At March 31, 2023 $ 37,431 $ 8,196 $ 173 $ 45,800 At December 31, 2022 $ 38,216 $ 9,543 $ 197 $ 47,956 During the three months ended March 31, 2023 and 2022, the Company recorded depreciation expense of $3,106 $4,223

NOTE 5 - INTANGIBLE ASSETS

NOTE 5 - INTANGIBLE ASSETS	3 Months Ended
	Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
NOTE 5 - INTANGIBLE ASSETS	NOTE 5 - INTANGIBLE ASSETS Patents A Patent on the Internet-Search Mechanism (“IBSM”) has been granted in the United States, South Africa, and New Zealand. A Notice of Approval has also been issued for Canada. The patent is currently pending in the following areas: Australia, European Union, and the United Kingdom. Patents are reported at cost, less accumulated amortization and accumulated impairment loss. Costs include expenditure that is directly attributable to the acquisition of the asset. Once a patent is providing economic benefit to the Company, amortization is provided on a straight-line basis on all patents over their expected useful lives of 20 years. Intellectual Property Intellectual Property capitalizes costs of the Company’s qualifying internal research and developments . 7 years Trademarks The Company has the following trademarks. Mark Category Proprietor Country Class(es) Status Reg. Date. File No. CITIZENS JOURNALIST Words Bubblr Limited European Union 9 38 REGISTERED 16-Nov-2019 206382.EM.01 CITIZENS JOURNALIST Word Bubblr Limited United Kingdom 9 38 REGISTERED 05-Jul-2019 206382.GB.01 CITIZENS JOURNALIST Words Bubblr Limited United Kingdom 9 38 REGISTERED 16-Nov-2019 206382.GB.02 CITIZENS JOURNALIST Word Bubblr Limited United States 9 38 41 42 REGD-DEC USE 08-Feb-2022 206382.US.01 Words and Color Device Bubblr Limited European Union 9 38 REGISTERED 16-Nov-2019 206383.EM.01 Series of Logos Bubblr Limited United Kingdom 9 38 REGISTERED 05-Jul-2019 206383.GB.01 Words and Color Device Bubblr Limited United Kingdom 9 38 REGISTERED 16-Nov-2019 206383.GB.02 Words and Device Bubblr Limited United States 9 38 41 42 ACCEPTED 206383.US.01 BAU NOT OK/BAU Not OK Series of Marks Bubblr Limited United Kingdom 9 38 REGISTERED 11-Oct-2019 208674.GB.01 NEWZMINE/NewzMine Series of Marks Bubblr Limited United Kingdom 9 38 42 REGISTERED 25-Dec-2020 227753.GB.01 The Company capitalizes trademark costs where the likelihood of acceptance is expected. Each trademark has been determined to have an infinite useful life and is assessed each reporting period for impairment. If there has been a reduction in the value of the trademark or if the trademark is not successfully registered, the asset will be impaired and charged to expense in the period of impairment. As of March 31, 2023 and December 31, 2022, trademarks consisted of the following: March 31, December 31, 2023 2022 Trademarks: NewzMine TM $ 9,920 $ 9,920 Citizens Journalist™ 25,367 25,367 Effects of currency translation ( 2,830 ) ( 3,461 ) $ 32,457 $ 31,826 As of March 31, 2023 and December 31, 2022, intangible assets consisted of the following: Cost Patents Trademarks Intellectual Property Capitalized Acquisition Costs Total At December 31, 2022 $ 168,300 $ 31,826 $ 2,764,198 $ 45,745 $ 3,010,069 Additions 11,138 — — — 11,138 Effects of currency translation 3,337 631 54,822 — 58,790 At March 31, 2023 $ 182,775 $ 32,457 $ 2,819,020 $ 45,745 $ 3,079,997 Less accumulated amortization At December 31, 2022 $ 4,947 $ — $ 1,674,551 $ 4,576 $ 1,684,074 Amortization expense 12,569 — 43,380 572 56,521 Effects of currency translation 98 — 33,211 — 33,309 At March 31, 2023 $ 17,614 $ — $ 1,751,142 $ 5,148 $ 1,773,904 Net book value At March 31, 2023 $ 165,161 $ 32,457 $ 1,067,878 $ 40,597 $ 1,306,093 At December 31, 2022 $ 163,353 $ 31,826 $ 1,089,647 $ 41,169 $ 1,325,995 During the three months ended March 31, 2023 and 2022, the Company purchased $11,138 $11,684 $56,521 $101,193 $0 $0 Three months ended March 31, Patents Intellectual Property Capitalized Acquisition Costs Total 9 months remaining 2023 $ 6,194 $ 114,416 $ 1,716 $ 122,326 2024 8,258 152,554 2,288 163,100 2025 8,258 152,554 2,288 163,100 2026 8,258 152,554 2,288 163,100 2027 8,258 152,554 2,288 163,100 2028 8,258 152,554 2,288 163,100 Thereafter 117,677 190,692 27,441 335,810 $ 165,161 $ 1,067,878 $ 40,597 $ 1,273,636

NOTE 6 _ ACCRUED LIABILITIES

NOTE 6 – ACCRUED LIABILITIES	3 Months Ended
	Mar. 31, 2023
Payables and Accruals [Abstract]
NOTE 6 – ACCRUED LIABILITIES	NOTE 6 – ACCRUED LIABILITIES As of March 31, 2023 and December 31, 2022, accrued liabilities consisted of the following: March 31, December 31, 2023 2022 Accrued interest $ — $ 3,143 Dividends payable 21,672 22,133 Payroll payable 74,659 24,818 Total Accrued liabilities $ 96,331 $ 50,094

NOTE 7 _ LOAN PAYABLE

NOTE 7 – LOAN PAYABLE	3 Months Ended
	Mar. 31, 2023
Debt Disclosure [Abstract]
NOTE 7 – LOAN PAYABLE	NOTE 7 – LOAN PAYABLE On February 4, 2022, the Company issued a promissory note for the principal sum of $20,000 25% $20,000 $15,000 $5,000 In November 2019, the Company purchased a vehicle under a capital finance arrangement. The term of this loan is 5 years 6.90% $12,225 $11,987 $8,205 $10,465 During the three months ended March 31, 2023 and 2022, the Company made $2,430 $3,322 At March 31, 2023 future minimum payments under the loan are as follows: Total 2023 (nine months remaining in 2023) $ 7,403 2024 9,870 17,273 Less: Imputed interest 3,157 Loan payable 20,430 Loan payable – current 12,225 Loan payable - non-current $ 8,205

NOTE 8 - RELATED PARTY TRANSACT

NOTE 8 - RELATED PARTY TRANSACTIONS	3 Months Ended
	Mar. 31, 2023
Related Party Transactions [Abstract]
NOTE 8 - RELATED PARTY TRANSACTIONS	NOTE 8 - RELATED PARTY TRANSACTIONS Loans from Related Parties The Company had received a loan from a minority shareholder of $19,709 20% $18,228 $3,646 $21,874 $81,162 no $26,434 Activity on this loan to arrive at March 31, 2023 and December 31, 2022, balances is as follows: March 31, December 31, 2023 2022 Beginning Balance $ 18,152 $ 81,162 Effects of currency translation 76 (4,779 ) Loan Payable $ 18,228 $ 76,383 Addition $ 19,709 Repayment $ (18,228 ) $ (77,940 ) Ending Balance $ — $ 18,152 During the three months ended March 31, 2023 and 2022, the Company received proceeds on these loans of $0 $19,709 $18,228 $52,556 $0 $443 The Company has loans from our founder, Stephen Morris, with a balance of $1,171,970 $899,309 Loan 1. The loan is non-interest bearing and repayable on demand. On May 23, 2022, the Company entered an amendment to the Loan Agreement between Bubblr Limited and Mr. Morris to change the loan from a demand loan to have a maturity date on the earlier of (i) the completion of an offering by Bubblr, Inc., in the amount of no less than $7,500,000 in a public offering, or (ii) two years from the date of the amendment. In addition, on a date no later than five (5) business days from the completion of bridge financing of no less than $1.5 million USD the Company shall pay to Mr. Morris an amount equal to £115,000 GBP as an installment payment on the principal of the Loan, and the balance of the principal of the Loan shall be paid at the Maturity Date On September 6, 2022, the Company entered into a second amendment (the “Amendment”) with Bubblr Limited and Mr. Morris to add $60,000 On December 20, 2022, the Company entered into a third amendment (the “Amendment”) with Bubblr Limited and Mr. Morris to reduce the outstanding principal amount of the loan by $71,540 $71,540 Loan 2. On September 7, 2022, our wholly owned subsidiary, Bubblr Limited, entered into a new loan agreement (the “Loan Agreement”) with Mr. Morris for $501,049 3 years In aggregate the Company received $223,777 $0 $0 $66,000 Activity on this loan to arrive at March 31, 2023 and December 31, 2022, balances is as follows: Three Months Ended Year Ended December 31, 2023 2022 Beginning balance current $ 374,018 $ 428,117 Effects of currency translation 38,466 (42,619 ) Loan Payable 412,484 385,558 Additions 223,777 Conversion from preferred stock — 60,000 Assignment of advances receivable — (71,540 ) Ending balance – Current $ 636,261 $ 374,018 Beginning balance non-current $ 525,291 $ — Additions — 501,049 Effects of currency translation 10,418 24,242 Ending balance non-current $ 535,709 $ 525,291 Ending balance current and non-current $ 1,171,970 $ 899,309

NOTE 9 - WARRANT LIABILITY

NOTE 9 - WARRANT LIABILITY	3 Months Ended
	Mar. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
NOTE 9 - WARRANT LIABILITY	NOTE 9 - WARRANT LIABILITY The Company analyzed the warrants issued in connection with the Series C Convertible Preferred Stock (see Note 10) for derivative accounting consideration under ASC 815, Derivatives and Hedging, and determined that the instruments should be classified as a liability due to reset provisions and variability in exercise price resulting in there being no fixed value or explicit limit to the number of shares to be delivered upon exercise. ASC 815 requires us to assess the fair market value of the derivative liability at the end of each reporting period and recognize any change in the fair market value as other income or expense item. The Company determined our warrant liabilities to be a Level 3 fair value measurement during the year based on management’s estimate of the expected future cash flows required to settle the liabilities and used the Black Scholes pricing model to calculate the fair value as of March 31, 2023. The Black Scholes model requires six basic data inputs: the exercise or strike price, time to expiration, the risk-free interest rate, the current stock price, the estimated volatility of the stock price in the future, and the dividend rate. Changes to these inputs could produce a significantly higher or lower fair value measurement. The fair value of each warrant is estimated using the Black-Scholes valuation model. For the period ended March 31, 2023 the estimated fair values of the warrant liabilities measured on a recurring basis are as follows: Three Months Ended March 31, 2023 Expected term 1.96 - 2.50 years Expected average volatility 177 - 220% Expected dividend yield 8.33% Risk-free interest rate 1.50 – 4.73% The following table summarizes the changes in the warrant liabilities during the period ended March 31, 2023 and December 31, 2022: Fair Value Measurements Using Significant Unobservable Inputs (Level 3) Warrant liability as of December 31, 2022 $ 198,479 Addition of new warrants $ — Additional day-one loss — Change in fair value of warrant liability 72,519 Warrant liability as of March 31, 2023 $ 270,998 Warrant liability as of December 31, 2021 $ — Addition of new warrants $ 721,000 Additional day-one loss ( 28,043 ) Change in fair value of warrant liability ( 494,753 ) Warrant liability as of December 31, 2022 $ 198,479

NOTE 10 - STOCKHOLDERS_ EQUITY

NOTE 10 - STOCKHOLDERS’ EQUITY	3 Months Ended
	Mar. 31, 2023
Equity [Abstract]
NOTE 10 - STOCKHOLDERS’ EQUITY	NOTE 10 - STOCKHOLDERS’ EQUITY Preferred Stock The Company has authorized 25,000,000 $0.001 Series C Convertible Preferred Stock On March 4, 2022, the Company filed a Certificate of Designation with the Wyoming Secretary of State, which established 2,000 $1,200 The Company has the right to redeem the Series C Convertible Preferred Stock in accordance with the following schedule: · If all of the Series C Convertible Preferred Stock are redeemed within 90 calendar days from the issuance date thereof, the Company shall have the right to redeem the Series C Convertible Preferred Stock upon three business days of written notice at a price equal to 115% of the Stated Value together with any accrued but unpaid dividends. · If all of the Series C Convertible Preferred Stock is redeemed after 90 calendar days from the issuance date thereof, the Company shall have the right to redeem the Series C Convertible Preferred Stock upon three business days of written notice at a price equal to 120% of the Stated Value together with any accrued but unpaid dividends; and · The Company shall pay a dividend of 8% per annum on the Series C Convertible Preferred Stock. Dividends shall be paid quarterly, and at the Company’s discretion, in cash or Series C Convertible Preferred Stock. Dividends shall be deemed to accrue from the date of issuance of the Series C Convertible Preferred Stock whether or not earned or declared and whether or not there are profits, surplus, or other funds of the Company legally available for the payment of dividends. The Series C Convertible Preferred Stock will vote together with the common stock on an as-converted basis subject to the Beneficial Ownership Limitations (as set forth in the Certificate of Designation). Each share of the Series C Convertible Preferred Stock is convertible, at any time and from time to time from and after the issuance at the option of the Holder thereof, into that number of shares of Common Stock (subject to Beneficial Ownership Limitations) determined by dividing the Stated Value of $1,200 $0.3202 On March 4, 2022, the Company entered into a Securities Purchase Agreement (the “GHS Securities Purchase Agreement”) with GHS Investments, LLC (“GHS”), whereby GHS agreed to purchase, in tranches, up to $700,000 700 On March 4, 2022, the Company issued to GHS the first tranche of 300 35 941,599 75% GHS delivered gross proceeds of $266,000 On March 9, 2022, the Company entered a Securities Purchase Agreement with Proactive Capital Partners LP (“Proactive”), whereby Proactive agreed to purchase 160 The Company agreed to issue Proactive commitment shares of 8 472,205 75% On March 9, 2022, the Company issued 168 shares of Series C Convertible Preferred stock to Proactive Capital Partners LP as per the Securities Purchase Agreement. $155,000 On April 24, 2022, the Company issued the second tranche of 200 hares of Series C Convertible Preferred Stock and 562,149 warrant shares as per its Securities Purchase Agreement (the “GHS Securities Purchase Agreement”) with GHS Investments, LLC (“GHS”), of March 4, 2022. $184,000 On May 25, 2022, the Company issued the third tranche of 100 hares of Series C Convertible Preferred Stock and 281,074 warrant shares as per its Securities Purchase Agreement (the “GHS Securities Purchase Agreement”) with GHS Investments, LLC (“GHS”), of March 4, 2022. $92,000 On June 24, 2022, the Company issued the fourth tranche of 100 hares of Series C Convertible Preferred Stock and 281,074 warrant shares as per its Securities Purchase Agreement (the “GHS Securities Purchase Agreement”) with GHS Investments, LLC (“GHS”), of March 4, 2022. $92,000 On September 7, 2022, our wholly owned subsidiary, Bubblr Limited, entered into a new loan agreement (the “Loan Agreement”) with Mr. Morris for £434,060 ( $535,709 USD at March 31, 2023). In order to enter into the new loan, GHS Investments, LLC agreed to waive a prohibition on borrowing over $200,000 found in our Certificate of Designation for the Series C Preferred Stock, in exchange for our company issuing 345,220 shares of common stock: 281,000 shares of common stock to GHS and 64,220 shares of common stock to Proactive. The resulting common shares were valued at $71,703 , which was recorded as interest expense. As a result of the above transactions, the Company received total net proceeds of $789,000 $721,275 $28,043 $95,768 As at March 31, 2023 and December 31, 2022, the Company had 903 Common Stock The Company has authorized 3,000,000,000 $0.01 During the three months ended March 31, 2023 and 2022, the Company issued common shares as follows: Three months ended March 31, 2022; the Company issued the following unregistered securities. · 147,960 shares for Executive Board Chair services valued at $75,460 . · 19,250 shares for Investor Relations services valued at $8,980 . · 587,039 shares as commitment shares under the Equity Financing Agreement with GHS. · 206,000 shares to White Lion Capital, LLC as a result of a Termination and Release Agreement. · 503 shares of Series C Preferred Stock and 75% warrant coverage in connection with Securities Purchase Agreements with GHS and Proactive Three months ended March 31, 2023; the Company issued the following unregistered securities. · 183,676 shares for dividend due of Series C Preferred Stock to December 31, 2022, valued at $22,133 . · 1,455,784 shares for Investor Relations services valued at $285,338 . As at March 31, 2023 and December 31, 2022, the Company had 155,948,778 154,309,318 Warrants The Company identified conversion features embedded within warrants issued during the three months ended March 31, 2022. The Company has determined that the conversion feature of the Warrants represents an embedded derivative since the conversion price includes a reset provision which could cause adjustments in redemption value and the number of shares issued upon exercise (see Note 9 - Warrant Liability). A summary of activity during the three-month period ended March 31, 2023 follows: Warrants Outstanding Number of Weighted Average Weighted Average Remaining life Warrants Exercise Price (years) Outstanding, December 31, 2022 2,538,101 $ 0.32 4.27 Granted — — — Exercised — — — Forfeited/canceled — — — Outstanding, March 31, 2023 2,538,101 $ 0.32 4.02 Exercisable Warrants, March 31, 2023 2,538,101 $ 0.32 4.02 The following table summarizes information relating to outstanding and exercisable warrants as of March 31, 2023: Warrants Outstanding Warrants Exercisable Number of Warrants Weighted Average Remaining Contractual life Weighted Average Exercise Price Number of Shares Weighted Average Exercise Price 941,599 3.93 $ 0.34 941,599 $ 0.34 472,205 3.94 0.34 472,205 0.34 562,149 4.07 0.35 562,149 0.35 281,074 4.15 0.22 281,074 0.22 281,074 4.24 0.22 281,074 0.22 2,538,101 4.02 $ 0.32 2,538,101 $ 0.32 As at March 31, 2023 the intrinsic value of the warrants is $0 Equity Incentive Plan On May 25, 2022, our board of directors and majority shareholders approved the adoption of the Bubblr, Inc. 2022 Equity Incentive Plan (the “2022 Equity Incentive Plan”) and, unless earlier terminated, will continue until May 25, 2032. A total of 28,400,000 If the employee is terminated for cause, the employee will forfeit the Restricted Stock Units (“RSUs”) awarded to date. 8,400,000 4,200,000 8,400,000 The RSUs were valued at $2,259,600 $0.269 $659,052 $1,600,548 On January 31, 2023 (the “Termination Date”), the award of 8,400,000 prior to the award being fully vested is not recognized as an expense, and any previously recognized costs are reversed upon forfeiture. As a result, the remaining unvested stock compensation of $1,600,548 was not recognized, and prior year recognition of $659,052 in compensation was reversed on the Termination Date. Equity Financing Agreements On February 1, 2022, Bubblr, Inc. entered into a Stock Purchase Agreement (the “SPA”) and Registration Rights Agreement with White Lion Capital LLC (“WLC”). Pursuant to the SPA, the Company had the right, but not the obligation, to cause WLC to purchase up to $10 million of our common stock during the period beginning on February 1, 2022, and ending on the earlier of (i) the date on which the WLC had purchased $10 million of our common stock pursuant to the SPA, or (ii) December 31, 2022. In consideration for entering into the SPA, on February 1, 2022 the Company issued 103,000 $93,792 On March 22, 2022, the Company entered into a Termination and Release Agreement with WLC to extinguish the SPA and Registration Rights Agreement in exchange for the issuance of 103,000 $51,500 On March 4, 2022, the Company entered into an Equity Financing Agreement (the “EFA”) and Registration Rights Agreement with GHS Investments LLC (“GHS”). Under the terms of the EFA, GHS agreed to provide the Company with up to $15 million upon effectiveness of a registration statement on Form S-1 filed with the U.S. Securities and Exchange Commission. The registration statement on Form S-1 was effective as of June 24, 2022. During the year ended December 31, 2022 GHS has provided $0 In consideration for entering the EFA, on March 4, 2022 the Company issued 587,039 $234,522

NOTE 11 - COMMITMENTS AND CONTI

NOTE 11 - COMMITMENTS AND CONTINGENCIES	3 Months Ended
	Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
NOTE 11 - COMMITMENTS AND CONTINGENCIES	NOTE 11 - COMMITMENTS AND CONTINGENCIES Premises During the three months ended March 31, 2023 and 2022, the Company paid $0 $1,969 July 14, 2022 $100 During the three months ended March 31, 2023 and 2022, the Company paid $600 $600 On March 25, 2022, the Company entered into a service agreement with PCG Advisory, Inc. The term was six months $7,000 $7,000 Service Contracts On February 14, 2023 the Company entered into a service agreement with Beyond Media SEZC. The term is twelve months $7,000 1,000,000 $180,000 On February 23, 2023 the Company entered into a service agreement with Milestone Management Services, LLC. The term is six months 325,000 $84,338 Employment Agreements On May 31, 2022, our board of directors approved amended and restated employment agreements in favor of our then-Chief Executive Officer, Rik Willard, and our then-Chief Commercial Officer, Steven Saunders. The employment agreement with Mr. Willard was amended as follows. In addition to his cash compensation, the Company agreed to further compensate Mr. Willard in accordance with our May 25, 2022, Equity Incentive Plan with 5,400,000 restricted stock units, which vest 2,700,000 annually over a period of two years. He was also entitled to health and vacation benefits and six-month severance if terminated for good cause or if he resigns for good reason in a constructive termination. He was also entitled to vesting of the restricted stock units upon any termination of employment by the Company. Mr. Willard agreed to a two-year non-solicit restrictive covenant. The agreement will automatically be renewed for a further year on May 31, 2023. The employment agreement with Mr. Saunders was amended as follows. In addition to his cash compensation, the Company agreed to further compensate Mr. Saunders in accordance with our May 25, 2022, Equity Incentive Plan with 3,000,000 restricted stock units, which vests 1,500,000 annually over a period of two years. He was also entitled to health and vacation benefits and six-month severance if terminated for good cause or if he resigns for good reason in a constructive termination. He was also entitled to vesting of the restricted stock units upon any termination of employment by the Company. Mr. Saunders agreed to a two-year non-solicit restrictive covenant. On January 31, 2023 Steven Saunders and Rik Willard entered into a separation agreement with the Company regarding the terms and conditions of their departures from the Company. Pursuant to the provisions of the Separation Agreement with Mr. Saunders and in consideration for a complete release of claims, we agreed as follows: • As of the date of the Separation Agreement, Mr. Saunders is no longer an officer or director of our company, and all prior agreements with Mr. Saunders, including his employment agreement, are terminated in their entirety. • We agreed to pay a lump sum of $24,000 • We agreed to pay $73,500 • Final payment of $18,000 Mr. Saunders forfeited 3,000,000 2022 Equity Incentive Plan. Pursuant to the provisions of the Separation Agreement with Mr. Willard and in consideration for a complete release of claims, we agreed as follows: • As of the date of the Separation Agreement, Mr. Willard is no longer an officer or director of our company, and all prior agreements with Mr. Willard, including his employment agreement, are terminated in their entirety • We agreed to pay a lump sum of $12,801 • We agreed to pay $75,806 • We agreed to pay $4,806 • The final payment of $18,000 • Our shareholder, Stephen Morris, has agreed to transfer to Mr. Willard 1,750,000 Mr. Willard forfeited 5,400,000 2022 Equity Incentive Plan. On February 10, 2023 The Company entered into an employment agreement with Mr. Chetwood that provides we will compensate him with a yearly salary of $180,000 102,040

NOTE 12 - SUBSEQUENT EVENTS

NOTE 12 - SUBSEQUENT EVENTS	3 Months Ended
	Mar. 31, 2023
Subsequent Events [Abstract]
NOTE 12 - SUBSEQUENT EVENTS	NOTE 12 - SUBSEQUENT EVENTS The Company has evaluated subsequent events through the date of issuance of these consolidated financial statements and noted the following events requiring disclosure: Marketing Services On May 1, 2023 the Company entered into a consulting agreement with Out of the Box Capital Inc. The term is six months commencing May 1, 2023. Out of the Box Capital Inc. is entitled to 625,000 shares of common stock valued at $100,000 in consideration for entrance into the agreement. 325,000 shares of common stock were issued May 01, 2023, with the balance of 325,000 due August 1, 2023. Employment Agreements On April 1, 2023 our board of directors approved an employment agreement and stock option grant in favor of our Chief Executive Officer, Mr. Burks. The employment agreement with Mr. Burks provides that we will compensate him with a yearly salary of $600,000, with payment reduced to $240,000 per annum upon securing $5million in debt or financing. We also agreed to grant Mr. Burks an option to purchase 4,800,000 shares of common stock, at $0.17 per share, with 40% vesting after 90 days of service and 60% vesting monthly over the following two years. He is also entitled to health and vacation benefits and, after 90 days of employment, six-month severance if terminated for good cause or if he resigns for good reason in a constructive termination. Mr. Burks agreed to a two-year non-solicit restrictive covenant. The amended employment agreement with Mr. Chetwood provides that we will compensate him with a yearly salary of $450,000, with payments reduced to $180,000 per annum until securing $5million in debt or financing. We also agreed to grant Mr. Chetwood 3,360,000 Stock Options with 40% vesting after 90 days of service and 60% vesting monthly over the following two years. He is also entitled to health and vacation benefits and, after 90 days of employment, six-month severance if terminated for good cause or if he resigns for good reason in a constructive termination. Mr. Chetwood agreed to a two-year non-solicit restrictive covenant. The amended employment agreement with Mr. Morris provides that we will compensate him with a yearly salary of $450,000, with payments reduced to $180,000 per annum until securing $5m in debt or financing. We also agreed to grant Mr. Morris an option to purchase 3,360,000 shares of common stock at $0.187 per share, fully vested. He is also entitled to health and vacation benefits and six-month severance if terminated for good cause or if he resigns for good reason in a constructive termination. Mr. Morris agreed to a two-year non-solicit restrictive covenant. On April 6, 2023 our board of directors approved a Non-Executive Board Agreement and Stock Option Grant in favor of Mr. Morrissey. The agreement with Mr. Morrissey provides that we will compensate him with a yearly fee of $300,000, paid monthly but reduced to $120,000 until securing $5million in debt or financing. We also agreed to grant Mr. Morrissey an option to purchase 1,920,000 shares of common stock, at $0.155 per share, with 40% vesting after 90 days of service and 60% vesting monthly over the following two years. He is also entitled to six-month severance if terminated for good cause or if he resigns for good reason in a constructive termination. Mr. Morrissey agreed to a two-year non-solicit restrictive covenant.

NOTE 1 - ORGANIZATION, BUSINE_2

NOTE 1 - ORGANIZATION, BUSINESS AND LIQUIDITY (Policies)	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Organization and Operations	Organization and Operations On March 26, 2020, Bubblr Holdings Ltd. (a UK company formed on February 18, 2016) merged into U.S. Wireless Online, Inc. (“UWRL”), a Wyoming corporation formed on October 22, 2019 100% Bubblr, Inc. is a Mobile Application software company that is currently developing its disruptive Internet Search Mechanism and seeking license opportunities for a next-generation solution designed to create an alternative economic model.
Going Concern Matters	Going Concern Matters The accompanying consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America (“GAAP”), which contemplates the Company’s continuation as a going concern. The Company incurred a net comprehensive loss of $273,478 $13,151,445 $1,097,435 Management intends to raise additional operating funds through equity and/or debt offerings. However, there can be no assurance management will be successful in its endeavors. There are no assurances that the Company will be able to either (1) achieve a level of revenues adequate to generate sufficient cash flow from operations; or (2) obtain additional financing through either private placement, public offerings, and/or bank financing necessary to support its working capital requirements. To the extent that funds generated from operations and any private placements, public offerings, and/or bank financing are insufficient, the Company will have to raise additional working capital. No assurance can be given that additional financing will be available, or if available, will be on terms acceptable to the Company. If adequate working capital is not available to the Company, it may be required to curtail or cease its operations. Due to uncertainties related to these matters, there exists substantial doubt about the ability of the Company to continue as a going concern. The accompanying consolidated financial statements do not include any adjustments related to the recoverability or classification of asset-carrying amounts or the amounts and classification of liabilities that may result should the Company be unable to continue as a going concern.
COVID-19	COVID-19 A novel strain of coronavirus (COVID-19) was first identified in December 2019 and subsequently declared a global pandemic by the World Health Organization on March 11, 2020. As a result of the outbreak, many companies have experienced disruptions in their operations and in the markets served. The Company has instituted some and may take additional temporary precautionary measures intended to help ensure the well-being of its employees and minimize business disruption. The Company considered the impact of COVID-19 on the assumptions and estimates used and determined that there were no material adverse impacts on the Company’s results of operations and financial position as at March 31, 2023. The full extent of the future impacts of COVID-19 on the Company’s operations is uncertain. A prolonged outbreak could have a material adverse impact on the financial results and business operations of the Company, including the timing and ability of the Company to collect accounts receivable and the ability of the Company to continue to provide high-quality services to its clients. The Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities at the date of issuance of these financial statements. These estimates may change as new events occur, and additional information is obtained.

NOTE 2 - SIGNIFICANT ACCOUNTI_2

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES (Policies)	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying consolidated interim financial statements have been prepared in accordance with GAAP. The Company’s fiscal year-end is December 31.
Principles of Consolidation	Principles of Consolidation The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries: Bubblr Holdings Ltd., Bubblr Ltd., and Bubblr CLN Ltd. All significant inter-company balances and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Some of these judgments can be subjective and complex, and, consequently, actual results may differ from these estimates.
Convertible Financial Instruments	Convertible Financial Instruments The Company bifurcates conversion options from their host instruments and accounts for them as free-standing derivative financial instruments if certain criteria are met. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not remeasured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur, and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. An exception to this rule is when the host instrument is deemed to be conventional, as that term is described under applicable GAAP.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company accounts for financial instruments in accordance with ASC 820, “Fair Value Measurements and Disclosures.” ASC 820 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy under ASC 820 are described below: Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. Level 2 – Quoted prices in non-active markets or in active markets for similar assets or liabilities, observable inputs other than quoted prices, and inputs that are not directly observable but are corroborated by observable market data. Level 3 – Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable. The carrying value of the Company’s current assets and liabilities are deemed to be their fair value due to the short-term maturity and realization. During the year ended December 31, 2022, the Company acquired warrant derivative liabilities, which are Level 3 financial instruments that are adjusted to fair market value on reporting dates. At March 31, 2023 and December 31, 2022 the warrant liabilities balances were $270,998 $198,479
Stock Based Compensation	Stock Based Compensation We follow ASC Topic 718, Compensation–Stock Compensation, Restricted stock units (“RSUs”) issued as compensation in accordance with the Company’s 2022 Equity Incentive Plan are deemed to be unissued until fully vested. RSU compensation is recognized as expense over the vesting period. Upon repurchase of the award any unrecognized compensation, net of cash payments are expensed immediately. Awards forfeited due to unfulfillment of obligations, such as termination of employment prior to the award being fully vested, for no cash or other consideration, are not recognized as an expense and any previously recognized costs are reversed in the period of forfeiture.
Common Stock Purchase Warrants and Derivative Financial Instruments	Common Stock Purchase Warrants and Derivative Financial Instruments Common stock purchase warrants and other derivative financial instruments are classified as equity if the contracts (1) require physical settlement or net-share settlement or (2) give the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). Contracts which (1) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company), (2) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement), or (3) that contain reset provisions that do not qualify for the scope exception are classified as liabilities. The Company assesses the classification of its common stock purchase warrants and other derivatives at each reporting date to determine whether a change in classification between equity and liabilities is required.
Basic and Diluted Net Loss per Common Share	Basic and Diluted Net Loss per Common Share Pursuant to ASC 260, “Earnings Per Share,” basic net income and net loss per share are computed by dividing the net income and net loss by the weighted average number of common shares outstanding. Diluted net income and net loss per share is the same as basic net income and net loss per share when their inclusion would have an anti-dilutive effect due to our continuing net losses. For the three months ended March 31, 2023 and 2022, the following outstanding stock was excluded from the computation of diluted net loss per share as the result of the computation was anti-dilutive. March 31, 2023 2022 (Shares) (Shares) Series C Preferred Stock 3,384,135 1,885,072 Warrants 2,358,101 1,413,804 Convertible Notes — 2,007,994 Total 5,742,236 5,306,870
Foreign Currency Translations	Foreign Currency Translations The functional currency of the Company’s international subsidiaries is generally their local currency of Great British pounds (GBP). Local currency assets and liabilities are translated at the rates of exchange on the balance sheet date, and local currency revenues and expenses are translated at weighted average rates of exchange during the period. Equity accounts are translated at historical rates. The resulting translation adjustments are recorded directly into accumulated other comprehensive income. March 31, December 31, 2023 2022 2022 Period-end GBP£:US$ exchange rate 1.2341 1.3139 1.2101 Weighted average GBP£:US$ exchange rate 1.2152 1.3412 1.2430 Aggregate transaction gains or losses, including gains or losses related to foreign-denominated cash and cash equivalents and the re-measurement of certain inter-company balances, are included in the statement of operations as other income and expense. Gains on foreign exchange transactions totaling $21,175 $40,707
Income Taxes	Income Taxes The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, “Income Taxes”. The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized. As of March 31, 2023 and December 31, 2022, the Company did not have any amounts recorded pertaining to uncertain tax positions. UK Taxes We do not consider ourselves to be engaged in a trade or business in the UK and, as such, do not expect to be subject to UK corporate income taxation. We have subsidiaries based in the UK that are subject to the tax laws of that country. Under current law, those subsidiaries are taxed at the applicable corporate income tax rates. Should any UK subsidiaries be deemed to undertake business activities in the US, they would be subject to US corporate income tax in respect of their US activities only. Relief would then be available against the UK tax liabilities in respect of the overseas taxes arising from US activities. At present, this is not applicable as our UK subsidiaries only undertake activities in the UK. Our UK subsidiaries file separate UK income tax returns. UK Tax Risk Companies that are incorporated outside the UK may become subject to UK taxes in a number of circumstances, including circumstances in which (1) they are deemed resident in the UK for tax purposes by reason of their central management and control being exercised from the UK or (2) they are treated as carrying on a trade, investing or carrying on any other business activity in the UK, whether or not through a UK Permanent Establishment (“PE”). In addition, the Finance Act 2015 introduced a new tax known as the diverted profits tax (“DPT”), which is charged at 25% However, this result is based on certain legal and factual determinations, and since the scope and the basis upon which the DPT will be applied by HM Revenue & Customs (“HMRC”) in the UK remains uncertain and since applicable law and regulations do not conclusively define the activities that constitute conducting a trade, investment or business activity in the UK (whether or not through a UK PE), and since we cannot exclude the possibility that there will be a change in law that adversely affects the analysis, HMRC might successfully assert a contrary position. The terms of an income tax treaty between the UK and the home country of the relevant Bubblr subsidiary, if any, could contain additional protections against UK tax. Any arrangements between UK-resident entities of Bubblr and other entities of Bubblr are subject to the UK transfer pricing regime. Consequently, if any agreement between a UK resident entity of Bubblr and any other Bubblr entity (whether that entity is resident in or outside of the UK) is found not to be on arm’s length terms and, as a result, a UK tax advantage is being obtained, an adjustment will be required to compute UK taxable profits as if such an agreement were on arm’s length terms. Any transfer pricing adjustment could adversely impact the tax charge incurred by the relevant UK resident entities of Bubblr.
Recent Accounting Pronouncements	Recent Accounting Pronouncements The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on our financial statements.

NOTE 2 - SIGNIFICANT ACCOUNTI_3

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES (Tables)	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES - Schedule of Anti-Dilutive Securities Excluded from Computation of Earnings per Share	March 31, 2023 2022 (Shares) (Shares) Series C Preferred Stock 3,384,135 1,885,072 Warrants 2,358,101 1,413,804 Convertible Notes — 2,007,994 Total 5,742,236 5,306,870
NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES - Schedule of Tranlation Adjustments	March 31, December 31, 2023 2022 2022 Period-end GBP£:US$ exchange rate 1.2341 1.3139 1.2101 Weighted average GBP£:US$ exchange rate 1.2152 1.3412 1.2430

NOTE 3 _ OTHER RECEIVABLES (Tab

NOTE 3 – OTHER RECEIVABLES (Tables)	3 Months Ended
	Mar. 31, 2023
Credit Loss [Abstract]
NOTE 3 - ACCOUNTS RECEIVABLE	March 31, December 31, 2023 2022 Deposit $ 200 $ 200 UK VAT Receivable 6,040 9,684 Other receivables $ 6,240 $ 9,884

NOTE 4 - PROPERTY AND EQUIPME_2

NOTE 4 - PROPERTY AND EQUIPMENT (Tables)	3 Months Ended
	Mar. 31, 2023
Property, Plant and Equipment [Abstract]
NOTE 4 - PROPERTY AND EQUIPMENT - Schedule of Property Pant and Equipment	Motor Vehicles Computer Equipment Office Equipment Total Cost At December 31, 2022 $ 56,875 $ 28,179 $ 563 $ 85,617 Additions — — — — Effects of currency translation 1,128 558 11 1,697 At March 31, 2023 $ 58,003 $ 28,737 $ 574 $ 87,314 Less accumulated depreciation At December 31, 2022 $ 18,659 $ 18,636 $ 366 $ 37,661 Depreciation expense 1,543 1,535 28 3,106 Effects of currency translation 370 370 7 747 At March 31, 2023 $ 20,572 $ 20,541 $ 401 $ 41,514 Net book value At March 31, 2023 $ 37,431 $ 8,196 $ 173 $ 45,800 At December 31, 2022 $ 38,216 $ 9,543 $ 197 $ 47,956

NOTE 5 - INTANGIBLE ASSETS (Tab

NOTE 5 - INTANGIBLE ASSETS (Tables)	3 Months Ended
	Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
NOTE 5 - INTANGIBLE ASSETS - Trademarks	March 31, December 31, 2023 2022 Trademarks: NewzMine TM $ 9,920 $ 9,920 Citizens Journalist™ 25,367 25,367 Effects of currency translation ( 2,830 ) ( 3,461 ) $ 32,457 $ 31,826
NOTE 5 - INTANGIBLE ASSETS - Schedule of Intangible Assets	Cost Patents Trademarks Intellectual Property Capitalized Acquisition Costs Total At December 31, 2022 $ 168,300 $ 31,826 $ 2,764,198 $ 45,745 $ 3,010,069 Additions 11,138 — — — 11,138 Effects of currency translation 3,337 631 54,822 — 58,790 At March 31, 2023 $ 182,775 $ 32,457 $ 2,819,020 $ 45,745 $ 3,079,997 Less accumulated amortization At December 31, 2022 $ 4,947 $ — $ 1,674,551 $ 4,576 $ 1,684,074 Amortization expense 12,569 — 43,380 572 56,521 Effects of currency translation 98 — 33,211 — 33,309 At March 31, 2023 $ 17,614 $ — $ 1,751,142 $ 5,148 $ 1,773,904 Net book value At March 31, 2023 $ 165,161 $ 32,457 $ 1,067,878 $ 40,597 $ 1,306,093 At December 31, 2022 $ 163,353 $ 31,826 $ 1,089,647 $ 41,169 $ 1,325,995
NOTE 5 - INTANGIBLE ASSETS - Amortization Expense	Three months ended March 31, Patents Intellectual Property Capitalized Acquisition Costs Total 9 months remaining 2023 $ 6,194 $ 114,416 $ 1,716 $ 122,326 2024 8,258 152,554 2,288 163,100 2025 8,258 152,554 2,288 163,100 2026 8,258 152,554 2,288 163,100 2027 8,258 152,554 2,288 163,100 2028 8,258 152,554 2,288 163,100 Thereafter 117,677 190,692 27,441 335,810 $ 165,161 $ 1,067,878 $ 40,597 $ 1,273,636

NOTE 6 _ ACCRUED LIABILITIES (T

NOTE 6 – ACCRUED LIABILITIES (Tables)	3 Months Ended
	Mar. 31, 2023
Payables and Accruals [Abstract]
NOTE 6 - ACCRUED LIABILITIES - Schedule of Accrued Liabilities	March 31, December 31, 2023 2022 Accrued interest $ — $ 3,143 Dividends payable 21,672 22,133 Payroll payable 74,659 24,818 Total Accrued liabilities $ 96,331 $ 50,094

NOTE 7 _ LOAN PAYABLE (Tables)

NOTE 7 – LOAN PAYABLE (Tables)	3 Months Ended
	Mar. 31, 2023
Debt Disclosure [Abstract]
NOTE 7 - LOANS PAYABLE - Future Minimum Payments	Total 2023 (nine months remaining in 2023) $ 7,403 2024 9,870 17,273 Less: Imputed interest 3,157 Loan payable 20,430 Loan payable – current 12,225 Loan payable - non-current $ 8,205

NOTE 8 - RELATED PARTY TRANSA_2

NOTE 8 - RELATED PARTY TRANSACTIONS (Tables)	3 Months Ended
	Mar. 31, 2023
Related Party Transactions [Abstract]
NOTE 8 - RELATED PARTY TRANSACTIONS - Shareholder Loan	March 31, December 31, 2023 2022 Beginning Balance $ 18,152 $ 81,162 Effects of currency translation 76 (4,779 ) Loan Payable $ 18,228 $ 76,383 Addition $ 19,709 Repayment $ (18,228 ) $ (77,940 ) Ending Balance $ — $ 18,152
NOTE 8 - RELATED PARTY TRANSACTIONS - Founder Loan	Three Months Ended Year Ended December 31, 2023 2022 Beginning balance current $ 374,018 $ 428,117 Effects of currency translation 38,466 (42,619 ) Loan Payable 412,484 385,558 Additions 223,777 Conversion from preferred stock — 60,000 Assignment of advances receivable — (71,540 ) Ending balance – Current $ 636,261 $ 374,018 Beginning balance non-current $ 525,291 $ — Additions — 501,049 Effects of currency translation 10,418 24,242 Ending balance non-current $ 535,709 $ 525,291 Ending balance current and non-current $ 1,171,970 $ 899,309

NOTE 9 - WARRANT LIABILITY (Tab

NOTE 9 - WARRANT LIABILITY (Tables)	3 Months Ended
	Mar. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
NOTE 9 - WARRANT LIABILITY - Fair Value of Warrant Liabilities Measured on a Recurring Basis	Three Months Ended March 31, 2023 Expected term 1.96 - 2.50 years Expected average volatility 177 - 220% Expected dividend yield 8.33% Risk-free interest rate 1.50 – 4.73%
NOTE 9 - WARRANT LIABILITY - Schedule of Changes in Warrant Liabilities	Fair Value Measurements Using Significant Unobservable Inputs (Level 3) Warrant liability as of December 31, 2022 $ 198,479 Addition of new warrants $ — Additional day-one loss — Change in fair value of warrant liability 72,519 Warrant liability as of March 31, 2023 $ 270,998

NOTE 10 - STOCKHOLDERS_ EQUITY

NOTE 10 - STOCKHOLDERS’ EQUITY (Tables)	3 Months Ended
	Mar. 31, 2023
Equity [Abstract]
NOTE 10 - STOCKHOLDERS EQUITY - Summary of Warrant Activity	Warrants Outstanding Number of Weighted Average Weighted Average Remaining life Warrants Exercise Price (years) Outstanding, December 31, 2022 2,538,101 $ 0.32 4.27 Granted — — — Exercised — — — Forfeited/canceled — — — Outstanding, March 31, 2023 2,538,101 $ 0.32 4.02 Exercisable Warrants, March 31, 2023 2,538,101 $ 0.32 4.02
NOTE 10 - STOCKHOLDERS EQUITY - Summary of Outstanding Warrants	Warrants Outstanding Warrants Exercisable Number of Warrants Weighted Average Remaining Contractual life Weighted Average Exercise Price Number of Shares Weighted Average Exercise Price 941,599 3.93 $ 0.34 941,599 $ 0.34 472,205 3.94 0.34 472,205 0.34 562,149 4.07 0.35 562,149 0.35 281,074 4.15 0.22 281,074 0.22 281,074 4.24 0.22 281,074 0.22 2,538,101 4.02 $ 0.32 2,538,101 $ 0.32

NOTE 1 - ORGANIZATION, BUSINE_3

NOTE 1 - ORGANIZATION, BUSINESS AND LIQUIDITY (Details Narrative) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Oct. 22, 2019
Entity Incorporation, Date of Incorporation	Oct. 22, 2019
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	$ 273,478	$ 273,478	$ 1,016,958
Retained Earnings (Accumulated Deficit)	13,151,445	$ 12,875,437
[custom:LiabilitiesCurrentInExcessOfAssetsCurrent-0]	$ 1,097,435
U W R L [Member]
Equity Method Investment, Ownership Percentage				100%

NOTE 2 - SIGNIFICANT ACCOUNTI_4

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES - Schedule of Anti-Dilutive Securities Excluded from Computation of Earnings per Share (Details) - shares	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Total	5,742,236	5,306,870
Preferred Stock [Member] | Series C Preferred Stock [Member]
Total	3,384,135	1,885,072
Derivative One [Member]
Total	2,358,101	1,413,804
Convertible Notes [Member]
Total		2,007,994

NOTE 2 - SIGNIFICANT ACCOUNTI_5

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES - Schedule of Tranlation Adjustments (Details)	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022
Accounting Policies [Abstract]
Period-end GBP£:US$ exchange rate	1.2341	1.2101	1.3139
Weighted average GBP£:US$ exchange rate	1.2152	1.2430	1.3412

NOTE 2 - SIGNIFICANT ACCOUNTI_6

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Dec. 31, 2021	Apr. 01, 2015
Accounting Policies [Abstract]
Derivative Liability, Securities Sold under Agreements to Repurchase, Securities Loaned, Not Subject to Master Netting Arrangement	$ 270,998		$ 198,479
Foreign Currency Transaction Loss, before Tax	$ 21,175	$ 40,707	$ (21,175)	$ 40,707
[custom:TaxableDivertedProfitsTaxPercentage-0]					25%

NOTE 3 - ACCOUNTS RECEIVABLE (D

NOTE 3 - ACCOUNTS RECEIVABLE (Details) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Credit Loss [Abstract]
Deposit	$ 200	$ 200
UK VAT Receivable	6,040	9,684
Other receivables	$ 6,240	$ 9,884

NOTE 4 - PROPERTY AND EQUIPME_3

NOTE 4 - PROPERTY AND EQUIPMENT - Schedule of Property Pant and Equipment (Details) - USD ($)	3 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	$ 87,314	$ 85,617
Property, Plant and Equipment, Additions	0
[custom:EffectsOfForeignCurrencyTranslationPropertyEquipment]	1,697
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	41,514	37,661
Accumulated Depreciation, Depletion and Amortization, Property, Plant and Equipment, Period Increase (Decrease)	3,106
Temporary Equity, Foreign Currency Translation Adjustments	747
Property, Plant and Equipment, Net	45,800	47,956
Automobiles [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	58,003	56,875
Property, Plant and Equipment, Additions
[custom:EffectsOfForeignCurrencyTranslationPropertyEquipment]	1,128
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	20,572	18,659
Accumulated Depreciation, Depletion and Amortization, Property, Plant and Equipment, Period Increase (Decrease)	1,543
Temporary Equity, Foreign Currency Translation Adjustments	370
Property, Plant and Equipment, Net	37,431
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	28,737	28,179
Property, Plant and Equipment, Additions	0
[custom:EffectsOfForeignCurrencyTranslationPropertyEquipment]	558
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	20,541	18,636
Accumulated Depreciation, Depletion and Amortization, Property, Plant and Equipment, Period Increase (Decrease)	1,535
Temporary Equity, Foreign Currency Translation Adjustments	370
Property, Plant and Equipment, Net	8,196	9,543
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	574	563
Property, Plant and Equipment, Additions	0
[custom:EffectsOfForeignCurrencyTranslationPropertyEquipment]	11
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	401	366
Accumulated Depreciation, Depletion and Amortization, Property, Plant and Equipment, Period Increase (Decrease)	28
Temporary Equity, Foreign Currency Translation Adjustments	7
Property, Plant and Equipment, Net	$ 173	197
Automobiles Quarterly [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Net		$ 38,216

NOTE 4 - PROPERTY AND EQUIPME_4

NOTE 4 - PROPERTY AND EQUIPMENT (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Property, Plant and Equipment [Abstract]
Depreciation	$ 3,106	$ 4,223

NOTE 5 - INTANGIBLE ASSETS - Tr

NOTE 5 - INTANGIBLE ASSETS - Trademarks (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Indefinite-Lived Intangible Assets [Line Items]
Indefinite-Lived Trademarks	$ 32,457	$ 31,826
Trademarks [Member]
Indefinite-Lived Intangible Assets [Line Items]
Realized Gain (Loss), Foreign Currency Transaction, before Tax	2,830	3,461
Newz Mine [Member]
Indefinite-Lived Intangible Assets [Line Items]
Indefinite-Lived Trademarks	9,920	9,920
Citizens Journalist [Member]
Indefinite-Lived Intangible Assets [Line Items]
Indefinite-Lived Trademarks	$ 25,367	$ 25,367

NOTE 5 - INTANGIBLE ASSETS - S

NOTE 5 - INTANGIBLE ASSETS - Schedule of Intangible Assets (Details) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Patents, Gross	$ 182,775		$ 168,300
Indefinite-Lived Trademarks	32,457		31,826
Capitalized Costs, Proved Properties	45,745		45,745
Finite-Lived Intangible Assets, Gross	3,079,997		3,010,069
Finite-Lived Intangible Assets, Period Increase (Decrease)	11,138	$ 11,684
Finite-Lived Intangible Assets, Accumulated Amortization	1,773,904		1,684,074
Amortization of Intangible Assets	56,521	$ 101,193
Finite-Lived Intangible Assets, Translation and Purchase Accounting Adjustments	33,309
Finite-Lived Intangible Assets, Net	1,306,093		1,325,995
Acquisition-related Costs [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss)	58,790
Intellectual Property [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross (Excluding Goodwill)	2,819,020		2,764,198
Finite-Lived Intangible Assets, Period Increase (Decrease)
Finite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss)	54,822
Finite-Lived Intangible Assets, Accumulated Amortization	1,751,142		1,674,551
Amortization of Intangible Assets	43,380
Finite-Lived Intangible Assets, Translation and Purchase Accounting Adjustments	33,211
Finite-Lived Intangible Assets, Net	1,067,878		1,089,647
Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Period Increase (Decrease)	11,138
Finite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss)	3,337
Finite-Lived Intangible Assets, Accumulated Amortization	17,614		4,947
Amortization of Intangible Assets	12,569
Finite-Lived Intangible Assets, Translation and Purchase Accounting Adjustments	98
Finite-Lived Intangible Assets, Net	165,161		163,353
Trademarks [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Period Increase (Decrease)
Finite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss)	631
Finite-Lived Intangible Assets, Accumulated Amortization
Amortization of Intangible Assets
Finite-Lived Intangible Assets, Translation and Purchase Accounting Adjustments
Finite-Lived Intangible Assets, Net	32,457		31,826
Acquisition-related Costs [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Period Increase (Decrease)
Finite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss)
Finite-Lived Intangible Assets, Accumulated Amortization	5,148		4,576
Amortization of Intangible Assets	572
Finite-Lived Intangible Assets, Translation and Purchase Accounting Adjustments
Finite-Lived Intangible Assets, Net	$ 40,597		$ 41,169

NOTE 5 - INTANGIBLE ASSETS - Am

NOTE 5 - INTANGIBLE ASSETS - Amortization Expense (Details) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Amortization Expense, Next Rolling 12 Months	$ 122,326
Finite-Lived Intangible Asset, Expected Amortization, Year Two	163,100
Finite-Lived Intangible Asset, Expected Amortization, Year Three	163,100
Finite-Lived Intangible Asset, Expected Amortization, Year Four	163,100
Finite-Lived Intangible Asset, Expected Amortization, Year Five	163,100
[custom:FiniteLivedIntangibleAssetsAmortizationExpenseYearSix-0]	163,100
Finite-Lived Intangible Asset, Expected Amortization, after Year Five	335,810
Finite-Lived Intangible Assets, Net	1,306,093	$ 1,325,995
[custom:FiniteLivedIntangibleAssetsAccumulatedAmortizationTotal-0]	1,273,636
Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Amortization Expense, Next Rolling 12 Months	6,194
Finite-Lived Intangible Asset, Expected Amortization, Year Two	8,258
Finite-Lived Intangible Asset, Expected Amortization, Year Three	8,258
Finite-Lived Intangible Asset, Expected Amortization, Year Four	8,258
Finite-Lived Intangible Asset, Expected Amortization, Year Five	8,258
[custom:FiniteLivedIntangibleAssetsAmortizationExpenseYearSix-0]	8,258
Finite-Lived Intangible Asset, Expected Amortization, after Year Five	117,677
Finite-Lived Intangible Assets, Net	165,161	163,353
Intellectual Property [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Amortization Expense, Next Rolling 12 Months	114,416
Finite-Lived Intangible Asset, Expected Amortization, Year Two	152,554
Finite-Lived Intangible Asset, Expected Amortization, Year Three	152,554
Finite-Lived Intangible Asset, Expected Amortization, Year Four	152,554
Finite-Lived Intangible Asset, Expected Amortization, Year Five	152,554
[custom:FiniteLivedIntangibleAssetsAmortizationExpenseYearSix-0]	152,554
Finite-Lived Intangible Asset, Expected Amortization, after Year Five	190,692
Finite-Lived Intangible Assets, Net	1,067,878	1,089,647
[custom:FiniteLivedIntangibleAssetsAccumulatedAmortizationTotal-0]	1,067,878
Acquisition-related Costs [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Amortization Expense, Next Rolling 12 Months	1,716
Finite-Lived Intangible Asset, Expected Amortization, Year Two	2,288
Finite-Lived Intangible Asset, Expected Amortization, Year Three	2,288
Finite-Lived Intangible Asset, Expected Amortization, Year Four	2,288
Finite-Lived Intangible Asset, Expected Amortization, Year Five	2,288
[custom:FiniteLivedIntangibleAssetsAmortizationExpenseYearSix-0]	2,288
Finite-Lived Intangible Asset, Expected Amortization, after Year Five	27,441
Finite-Lived Intangible Assets, Net	40,597	$ 41,169
[custom:FiniteLivedIntangibleAssetsAccumulatedAmortizationTotal-0]	$ 40,597

NOTE 5 - INTANGIBLE ASSETS (Det

NOTE 5 - INTANGIBLE ASSETS (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Period Increase (Decrease)	$ 11,138	$ 11,684
Amortization of Intangible Assets	56,521	101,193
Impairment of Intangible Assets, Finite-Lived	$ 0	$ 0
Intellectual Property [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	7 years
Finite-Lived Intangible Assets, Period Increase (Decrease)
Amortization of Intangible Assets	$ 43,380

NOTE 6 - ACCRUED LIABILITIES -

NOTE 6 - ACCRUED LIABILITIES - Schedule of Accrued Liabilities (Details) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Payables and Accruals [Abstract]
Accrued interest		$ 3,143
Dividends payable	21,672	22,133
Payroll payable	74,659	24,818
Total Accrued liabilities	$ 96,331	$ 50,094

NOTE 7 - LOANS PAYABLE - Future

NOTE 7 - LOANS PAYABLE - Future Minimum Payments (Details) - USD ($)	3 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Debt Disclosure [Abstract]
Long-Term Debt and Capital Lease Obligations, Maturities, Repayments of Principal Remainder of Fiscal Year	$ 7,403
Long-Term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Two	9,870
Long-Term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Three	17,273
Interest Paid, Including Capitalized Interest, Operating and Investing Activities	3,157
Loans Payable	20,430
Loans Payable, Current	12,225	$ 11,987
Loans Payable, Noncurrent	$ 8,205	$ 10,465

NOTE 7 _ LOAN PAYABLE (Details

NOTE 7 – LOAN PAYABLE (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended			12 Months Ended
	Apr. 26, 2022	Mar. 31, 2023	Apr. 26, 2022	Mar. 31, 2022	Dec. 31, 2022	Feb. 04, 2022
Short-Term Debt [Line Items]
Loans Payable, Current		$ 12,225			$ 11,987
Loans Payable, Noncurrent		8,205			10,465
Payments of Financing Costs		2,430
Payments for Loans		$ 2,430		$ 3,322	$ 3,322
White Lion Note [Member]
Short-Term Debt [Line Items]
Debt Instrument, Face Amount						$ 20,000
Debt Instrument, Interest Rate, Effective Percentage						25%
Payments of Debt Issuance Costs	$ 20,000
Proceeds from Notes Payable	$ 15,000
Amortization of Debt Discount (Premium)			$ 5,000
Vehicle [Member]
Short-Term Debt [Line Items]
Debt Instrument, Interest Rate, Effective Percentage		6.90%
Debt Instrument, Term		5 years

NOTE 8 - RELATED PARTY TRANSA_3

NOTE 8 - RELATED PARTY TRANSACTIONS - Shareholder Loan (Details) - USD ($)		1 Months Ended	3 Months Ended			12 Months Ended
	Feb. 15, 2023	Feb. 28, 2022	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2022
Related Party Transaction [Line Items]
Addition			$ 223,777	$ 19,709
Repayment			(2,430)	(3,322)		$ (3,322)
Shareholder Loans [Member]
Related Party Transaction [Line Items]
Debt Instrument, Face Amount					$ 81,162	18,152
Effects of currency translation			76			(4,779)
Loan Payable			18,228			76,383
Addition		$ 19,709			$ 81,162	19,709
Repayment	$ 21,874		$ (18,228)	$ (52,556)		$ (77,940)

NOTE 8 - RELATED PARTY TRANSAC

NOTE 8 - RELATED PARTY TRANSACTIONS - Founder Loan (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Founder Loan [Member]
Related Party Transaction [Line Items]
Long-Term Debt, Gross	$ 636,261	$ 374,018	$ 428,117
Effects of currency translation	38,466	(42,619)
Additions	223,777
Conversion from preferred stock	0	60,000
Assignment of advances receivable		(71,540)
[custom:NonCurrentBalanceOfLoansPayableRelatedParty-0]	535,709	525,291
Effects of currency translation	10,418	24,242
Loan, Held-in-Portfolio, Principal Outstanding	1,171,970	899,309
Founder Loan [Member] | Founder Loan [Member]
Related Party Transaction [Line Items]
Loan Payable	412,484	385,558
Bubblr Limited And Morris [Member]
Related Party Transaction [Line Items]
Increase (Decrease) in Other Loans		$ 501,049

NOTE 8 - RELATED PARTY TRANSA_4

NOTE 8 - RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)					1 Months Ended	3 Months Ended			12 Months Ended
	Feb. 15, 2023	Dec. 20, 2022	Sep. 07, 2022	Sep. 06, 2022	Feb. 28, 2022	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2022
Related Party Transaction [Line Items]
Proceeds from Related Party Debt						$ 223,777	$ 19,709
Interest Payable, Current									$ (3,143)
Repayment						(2,430)	(3,322)		(3,322)
Other Loans Payable, Current						636,261			392,170
Payments for Loans						2,430	3,322		3,322
Interest Payable, Current									3,143
Founder Loan [Member]
Related Party Transaction [Line Items]
Loan, Held-in-Portfolio, Principal Outstanding						$ 1,171,970			899,309
Debt Instrument, Call Feature						On May 23, 2022, the Company entered an amendment to the Loan Agreement between Bubblr Limited and Mr. Morris to change the loan from a demand loan to have a maturity date on the earlier of (i) the completion of an offering by Bubblr, Inc., in the amount of no less than $7,500,000 in a public offering, or (ii) two years from the date of the amendment.
Debt Instrument, Payment Terms						In addition, on a date no later than five (5) business days from the completion of bridge financing of no less than $1.5 million USD the Company shall pay to Mr. Morris an amount equal to £115,000 GBP as an installment payment on the principal of the Loan, and the balance of the principal of the Loan shall be paid at the Maturity Date
[custom:AssignmentOfAdvancesReceivable]									71,540
Founder Loan Amendment 2 [Member]
Related Party Transaction [Line Items]
Increase (Decrease) in Notes Payable, Related Parties				$ 60,000
Founder Loan Amendment 3 [Member]
Related Party Transaction [Line Items]
Increase (Decrease) in Notes Payable, Related Parties		$ 71,540
[custom:AssignmentOfAdvancesReceivable]		$ 71,540
Bubblr Limited And Morris [Member]
Related Party Transaction [Line Items]
Repayment						0	(66,000)
Proceeds from Loans						223,777	0
Payments for Loans						0	66,000
Debt Instrument, Face Amount			$ 501,049			535,709
Debt Instrument, Term			3 years
Shareholder Loans [Member]
Related Party Transaction [Line Items]
Proceeds from Related Party Debt					$ 19,709			$ 81,162	19,709
Debt Instrument, Interest Rate During Period					20%			0%
Loan, Held-in-Portfolio, Principal Outstanding	$ 18,228
Interest Payable, Current	3,646					0	(443)
Repayment	21,874					(18,228)	(52,556)		(77,940)
Other Loans Payable, Current							26,434
Proceeds from Loans						0	19,709
Payments for Loans	(21,874)					18,228	52,556		77,940
Interest Payable, Current	$ (3,646)					0	$ 443
Increase (Decrease) in Notes Payable, Related Parties						18,228			76,383
Debt Instrument, Face Amount								$ 81,162	$ 18,152

NOTE 9 - WARRANT LIABILITY - Fa

NOTE 9 - WARRANT LIABILITY - Fair Value of Warrant Liabilities Measured on a Recurring Basis (Details)	3 Months Ended
	Mar. 31, 2023
Derivative [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum	17,700%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum	220%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate	8.33%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum	150%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum	4.73%
Minimum [Member]
Derivative [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term	1 year 11 months 15 days
Maximum [Member]
Derivative [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term	2 years 6 months

NOTE 9 - WARRANT LIABILITY - Sc

NOTE 9 - WARRANT LIABILITY - Schedule of Changes in Warrant Liabilities (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Liability, Subject to Master Netting Arrangement, before Offset	$ 270,998	$ 198,479
Increase (Decrease) in Derivative Liabilities		721,000
Derivative, Loss on Derivative		(28,043)
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments	72,519	494,753
Derivative, Loss on Derivative		$ 28,043

NOTE 10 - STOCKHOLDERS EQUITY -

NOTE 10 - STOCKHOLDERS EQUITY - Summary of Warrant Activity (Details) - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2021	Dec. 31, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number	2,538,101		2,538,101
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.32		$ 0.32
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms	4 years 7 days	4 years 3 months 7 days
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedWeightedAverageExercisePrice]
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Intrinsic Value, Amount Per Share
Warrants Granted [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms
Warrants Exercised [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms
Warrants Forfeited [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms

NOTE 10 - STOCKHOLDERS EQUITY_2

NOTE 10 - STOCKHOLDERS EQUITY - Summary of Outstanding Warrants (Details) - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2021	Dec. 31, 2022	Jun. 24, 2022	Apr. 24, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number	2,538,101		2,538,101
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms	4 years 7 days	4 years 3 months 7 days
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.32		$ 0.32
G H S [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number	941,599
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms	3 years 11 months 4 days
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.34
Proactive [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number	472,205
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms	3 years 11 months 8 days
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.34
G H S Tranche 2 [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number	562,149				562,149
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms	4 years 25 days
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.35
G H S Tranche 3 [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number	281,074
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms	4 years 1 month 24 days
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.22
G H S Tranche 4 [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number	281,074			281,074
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms	4 years 2 months 26 days
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.22

NOTE 10 - STOCKHOLDERS_ EQUIT_2

NOTE 10 - STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)

1 Months Ended

3 Months Ended

12 Months Ended

Sep. 07, 2022

Mar. 22, 2022

Mar. 09, 2022

Mar. 04, 2022

Feb. 01, 2022

Jun. 24, 2022

May 25, 2022

Apr. 24, 2022

Mar. 31, 2023

Mar. 31, 2022

Mar. 31, 2021

Dec. 31, 2022

Dec. 31, 2021

Jan. 31, 2023

Class of Stock [Line Items]

Preferred Stock, Shares Authorized

25,000,000

Preferred Stock, Par or Stated Value Per Share

$ 0.001

Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number

2,538,101

2,538,101

Interest Expense

$ 1,129

$ 414,844

Derivative, Loss on Derivative

$ 28,043

Gain (Loss) on Securitization of Financial Assets

95,768

Preferred Stock, Shares Issued

903

Common Stock, Shares Authorized

3,000,000,000

Common Stock, Par or Stated Value Per Share

$ 0.01

Stock Issued During Period, Value, Issued for Services

285,338

$ 8,980

Stock Issued During Period, Value, Stock Dividend

$ 22,133

Common Stock, Shares, Outstanding

155,948,778

154,309,318

Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding

$ 0

[custom:VestingOfDeferredStockBasedCompensation]

659,052

Deferred Compensation Equity

$ 1,600,548

Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures

[custom:DeferredCompensationEquityReversed-0]

$ 659,052

Bubblr Limited And Morris [Member]

Class of Stock [Line Items]

Debt Instrument, Face Amount

$ 501,049

$ 535,709

Investment Company, Fee Waiver Terms

GHS Investments, LLC agreed to waive a prohibition on borrowing over $200,000 found in our Certificate of Designation for the Series C Preferred Stock, in exchange for our company issuing

G H S [Member]

Class of Stock [Line Items]

Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value

$ 700,000

Preferred Stock, Shares Subscribed but Unissued

700

Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number

941,599

Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants

$ 266,000

[custom:StockIssuedDuringPeriodValueCompensationLoanWaiverSeriesC]

$ 281,000

Debt Instrument, Unused Borrowing Capacity, Description

Under the terms of the EFA, GHS agreed to provide the Company with up to $15 million upon effectiveness of a registration statement on Form S-1 filed with the U.S. Securities and Exchange Commission.

Proceeds from Sale and Collection of Finance Receivables

$ 0

Proactive [Member]

Class of Stock [Line Items]

Preferred Stock, Shares Subscribed but Unissued

160

Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number

472,205

[custom:StockIssuedDuringPeriodValueCompensationLoanWaiverSeriesC]

64,220

Proactive Two [Member]

Class of Stock [Line Items]

Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants

$ 155,000

G H S Tranche 2 [Member]

Class of Stock [Line Items]

Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number

562,149

562,149

Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants

$ 184,000

G H S Tranche 3 [Member]

Class of Stock [Line Items]

Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number

281,074

G H S Tranche 4 [Member]

Class of Stock [Line Items]

Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number

281,074

281,074

Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants

$ 92,000

Proactive Total [Member]

Class of Stock [Line Items]

Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants

$ 789,000

Warrant Allocated [Member]

Class of Stock [Line Items]

Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants

$ 721,275

Advisory Board [Member]

Class of Stock [Line Items]

Stock Issued During Period, Shares, Issued for Services

147,960

Stock Issued During Period, Value, Issued for Services

$ 75,460

Investor Relations [Member]

Class of Stock [Line Items]

Stock Issued During Period, Shares, Issued for Services

1,455,784

19,250

Stock Issued During Period, Value, Issued for Services

$ 285,338

$ 8,980

Stock Dividends, Shares

183,676

Stock Issued During Period, Value, Stock Dividend

$ 22,133

Commitment Shares To G H S [Member]

Class of Stock [Line Items]

[custom:StockIssuedDuringPeriodEquityFinanceAgreementShares]

587,039

Termination Agreement White Lion [Member]

Class of Stock [Line Items]

[custom:StockIssuedDuringPeriodEquityFinanceAgreementShares]

206,000

Equity Incentive Plan [Member]

Class of Stock [Line Items]

[custom:StockIssuedDuringPeriodEquityFinanceAgreementShares]

28,400,000

Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights

4,200,000

Common Stock [Member]

Class of Stock [Line Items]

Stock Issued During Period, Shares, New Issues

Stock Issued During Period, Shares, Issued for Services

1,455,784

19,250

Stock Issued During Period, Value, Issued for Services

$ 14,558

$ 193

[custom:StockIssuedDuringPeriodEquityFinanceAgreementShares]

793,039

Stock Dividends, Shares

183,676

Stock Issued During Period, Value, Stock Dividend

$ 1,837

[custom:StockIssuedDuringPeriodSharesIssuedForDeferredCompensation]

8,400,000

Deferred Compensation, Share-Based Payments [Member]

Class of Stock [Line Items]

[custom:StockIssuedDuringPeriodValueIssuedForDeferredCompensation]

$ 2,259,600

Share-Based Compensation Arrangement by Share-Based Payment Award, Per Share Weighted Average Price of Shares Purchased

$ 0.269

R S U [Member]

Class of Stock [Line Items]

Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures

8,400,000

White Lion Capital [Member]

Class of Stock [Line Items]

Debt Instrument, Unused Borrowing Capacity, Description

Pursuant to the SPA, the Company had the right, but not the obligation, to cause WLC to purchase up to $10 million of our common stock during the period beginning on February 1, 2022, and ending on the earlier of (i) the date on which the WLC had purchased $10 million of our common stock pursuant to the SPA, or (ii) December 31, 2022.

Stock Issued During Period, Shares, Other

103,000

Stock Issued During Period, Value, Other

$ 93,792

White Lion Capital Termination Issuance [Member]

Class of Stock [Line Items]

Stock Issued During Period, Shares, Other

103,000

Stock Issued During Period, Value, Other

$ 51,500

G H S Consideration [Member]

Class of Stock [Line Items]

Stock Issued During Period, Shares, Other

587,039

Stock Issued During Period, Value, Other

$ 234,522

Series C Preferred Stock [Member]

Class of Stock [Line Items]

Preferred Stock, Shares Authorized

2,000

2,000

Preferred Stock, Par or Stated Value Per Share

$ 0.001

Preferred Stock, Value, Outstanding

$ 1,200

Preferred Stock, Dividend Rate, Percentage

8%

Preferred Stock, Conversion Basis

Each share of the Series C Convertible Preferred Stock is convertible, at any time and from time to time from and after the issuance at the option of the Holder thereof, into that number of shares of Common Stock (subject to Beneficial Ownership Limitations) determined by dividing the Stated Value of

Preferred Stock, Liquidation Preference, Value

$ 1,200

Preferred Stock, Convertible, Conversion Price

$ 0.3202

Preferred Stock, Shares Issued

903

Series C Preferred Stock [Member] | Redeemed Within 90 Days [Member]

Class of Stock [Line Items]

Debt Instrument, Redemption, Description

If all of the Series C Convertible Preferred Stock are redeemed within 90 calendar days from the issuance date thereof, the Company shall have the right to redeem the Series C Convertible Preferred Stock upon three business days of written notice at a price equal to 115% of the Stated Value together with any accrued but unpaid dividends.

Series C Preferred Stock [Member] | Redeemed After 90 Days [Member]

Class of Stock [Line Items]

Debt Instrument, Redemption, Description

If all of the Series C Convertible Preferred Stock is redeemed after 90 calendar days from the issuance date thereof, the Company shall have the right to redeem the Series C Convertible Preferred Stock upon three business days of written notice at a price equal to 120% of the Stated Value together with any accrued but unpaid dividends; and

Series C Preferred Stock [Member] | G H S [Member]

Class of Stock [Line Items]

Derivative, Nonmonetary Notional Amount, Percent of Required Need, Coverage

75%

Series C Preferred Stock [Member] | Tranche 1 [Member]

Class of Stock [Line Items]

Stock Issued During Period, Shares, New Issues

300

Series C Preferred Stock [Member] | Commitment Shares [Member] | G H S [Member]

Class of Stock [Line Items]

Stock Issued During Period, Shares, New Issues

35

Series C Preferred Stock [Member] | Commitment Shares [Member] | Proactive [Member]

Class of Stock [Line Items]

Stock Issued During Period, Shares, New Issues

8

Series C Preferred Stock [Member] | Proactive [Member]

Class of Stock [Line Items]

Stock Issued During Period, Shares, New Issues

168

Derivative, Nonmonetary Notional Amount, Percent of Required Need, Coverage

75%

Series C Preferred Stock [Member] | G H S Tranche 2 [Member]

Class of Stock [Line Items]

Stock Issued During Period, Shares, New Issues

200

Series C Preferred Stock [Member] | G H S Tranche 3 [Member]

Class of Stock [Line Items]

Stock Issued During Period, Shares, New Issues

100

Series C Preferred Stock [Member] | G H S Tranche 4 [Member]

Class of Stock [Line Items]

Stock Issued During Period, Shares, New Issues

100

Series C Preferred Stock [Member] | Preferred Stock [Member]

Class of Stock [Line Items]

Stock Issued During Period, Shares, New Issues

503

503

Derivative, Nonmonetary Notional Amount, Percent of Required Need, Coverage

75%

[custom:StockIssuedDuringPeriodValueCompensationLoanWaiverSeriesC]

$ 345,220

Interest Expense

$ 71,703

Stock Issued During Period, Shares, Issued for Services

Stock Issued During Period, Value, Issued for Services

[custom:StockIssuedDuringPeriodEquityFinanceAgreementShares]

Stock Dividends, Shares

Stock Issued During Period, Value, Stock Dividend

NOTE 11 - COMMITMENTS AND CON_2

NOTE 11 - COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)						3 Months Ended
	Feb. 23, 2023	Feb. 14, 2023	Feb. 10, 2023	Jul. 14, 2022	Apr. 01, 2022	Mar. 31, 2023	Mar. 31, 2022	Feb. 20, 2023
Other Commitments [Line Items]
Stock Issued During Period, Value, Issued for Services						$ 285,338	$ 8,980
Restricted Stock Award, Forfeitures						(659,052)
P C G Advisory [Member]
Other Commitments [Line Items]
[custom:InvestorRelationsAgreementTerm]					6 months
Payments to Suppliers						7,000
Share-Based Goods and Nonemployee Services Transaction, Modification of Terms, Incremental Compensation Cost						$ 7,000
Beyond Media S E Z C [Member]
Other Commitments [Line Items]
[custom:InvestorRelationsAgreementTerm]		12 months
Payments to Suppliers		$ 7,000
Stock Issued During Period, Shares, Issued for Services		1,000,000
Stock Issued During Period, Value, Issued for Services		$ 180,000
Milestone Management Services L L C [Member]
Other Commitments [Line Items]
[custom:InvestorRelationsAgreementTerm]	6 months
Stock Issued During Period, Shares, Issued for Services	325,000
Stock Issued During Period, Value, Issued for Services	$ 84,338
Willard Amended Agreement [Member]
Other Commitments [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Description						The employment agreement with Mr. Willard was amended as follows. In addition to his cash compensation, the Company agreed to further compensate Mr. Willard in accordance with our May 25, 2022, Equity Incentive Plan with 5,400,000 restricted stock units, which vest 2,700,000 annually over a period of two years. He was also entitled to health and vacation benefits and six-month severance if terminated for good cause or if he resigns for good reason in a constructive termination. He was also entitled to vesting of the restricted stock units upon any termination of employment by the Company. Mr. Willard agreed to a two-year non-solicit restrictive covenant. The agreement will automatically be renewed for a further year on May 31, 2023.
Saunders Amended Agreement [Member]
Other Commitments [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Description						The employment agreement with Mr. Saunders was amended as follows. In addition to his cash compensation, the Company agreed to further compensate Mr. Saunders in accordance with our May 25, 2022, Equity Incentive Plan with 3,000,000 restricted stock units, which vests 1,500,000 annually over a period of two years. He was also entitled to health and vacation benefits and six-month severance if terminated for good cause or if he resigns for good reason in a constructive termination. He was also entitled to vesting of the restricted stock units upon any termination of employment by the Company. Mr. Saunders agreed to a two-year non-solicit restrictive covenant.
Saunders [Member]
Other Commitments [Line Items]
Supplemental Unemployment Benefits, Severance Benefits								$ 24,000
Restricted Stock Award, Forfeitures						$ 3,000,000
Saunders Six Month Severance [Member]
Other Commitments [Line Items]
Severance Costs						73,500
Saunders Final Payment [Member]
Other Commitments [Line Items]
Payments for Postemployment Benefits						18,000
Willard [Member]
Other Commitments [Line Items]
Supplemental Unemployment Benefits, Severance Benefits								$ 12,801
Restricted Stock Award, Forfeitures						$ 5,400,000
[custom:CommonStockTransferredFromShareholderForServices]						1,750,000
Willard Six Month Severance [Member]
Other Commitments [Line Items]
Severance Costs						$ 75,806
Willard Six Month Severance Secondary [Member]
Other Commitments [Line Items]
Severance Costs						4,806
Willard Final Payment [Member]
Other Commitments [Line Items]
Payments for Postemployment Benefits						18,000
Chetwood [Member]
Other Commitments [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Description			On February 10, 2023 The Company entered into an employment agreement with Mr. Chetwood that provides we will compensate him with a yearly salary of $180,000, to be increased to $360,000 upon securing $5 million in debt or financing. We also agreed to compensate Mr. Chetwood with 102,040 restricted shares of our common stock upon the successful completion of his initial period of 90 days. He is also entitled to health and vacation benefits and two-month severance if terminated for good cause or if he resigns for good reason in a constructive termination. Mr. Chetwood agreed to a two-year non-solicit restrictive covenant.
Salary and Wage, Excluding Cost of Good and Service Sold			$ 180,000
Stock Issued During Period, Shares, Restricted Stock Award, Gross			102,040
Scotland Premisis [Member]
Other Commitments [Line Items]
Operating Lease, Payments						0	1,969
Lease Expiration Date				Jul. 14, 2022
Virtual Office Space [Member]
Other Commitments [Line Items]
Short-Term Lease, Cost						100
New York Premisis [Member]
Other Commitments [Line Items]
Operating Lease, Payments						$ 600	$ 600